HOME >> BIOLOGY >> NEWS
NIH establishes Center of Excellence for influenza research at Mount Sinai

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that Mount Sinai School of Medicine is a new Center of Excellence for Influenza Research and Surveillance. NIAID is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance around the country. Mount Sinai will help expand NIAIDs influenza research as the only recognized Center of Excellence for Influenza Research and Surveillance in New York City.

Mount Sinai welcomes this high honor bestowed by NIAID for our influenza virus research and recognition of our teams hard work, said Adolfo Garca-Sastre, Ph.D., principal investigator for research at Mount Sinais Center of Excellence for Influenza Research and Surveillance, Professor of Microbiology at Mount Sinai School of Medicine. We look forward to building upon our past research on the influenza virus, helping the federal government research findings in order to control and weaken the impact of influenza and stop the danger of a deadly influenza pandemic.

The Mount Sinai Center of Excellence for Influenza Research and Surveillance has been named Center for Research in Influenza Pathogenesis or CRIP. Mount Sinai researchers Adolfo Garca-Sastre and Peter Palese, in collaboration with Daniel Perez, at University of Maryland, and Ron Fouchier, at Erasmus Medical Center in Rotterdam, will continue to conduct molecular studies to identify influenza virus genes associated with the development of disease, the adaptability of flu viruses in birds and mammals, and the transmission of flu viruses between different hosts.

Mount Sinai is globally renowned for its research on the 1918 flu virus. The goal of Mount Sinais research is to gain greater understanding of the virus in order to use this knowledge to predict future pandemics and develop novel vaccines and treatments. In 2005, researchers re
'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
2-Apr-2007


Page: 1 2

Related biology news :

1. ConocoPhillips establishes $22.5M biofuels research program at Iowa State
2. AACR establishes new lecture in honor of Princess Takamatsu
3. Joslin Diabetes Center in Boston establishes first affiliate in Canada
4. Study establishes safety of spinal cord stem cell transplantation
5. DFG establishes 11 new research units
6. $7.3 million NIH grant establishes Wellstone Muscular Dystrophy Research Center at the UI
7. Study establishes new class of cancer-causing genes
8. $10 million gift establishes Helen L. & Martin S. Kimmel Center for Stem Cell Biology
9. NSF grant to Carnegie Mellon establishes research experiences for undergraduates site
10. Mount Sinai School of Medicine establishes Stem Cell Institute
11. DFG establishes three new clinical research units

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: